Key regions: Australia, Brazil, United Kingdom, Europe, Canada
The Other Vaccines market in Costa Rica has been developing steadily in recent years.
Customer preferences: Costa Rica has a well-established public healthcare system, which provides free vaccinations to its citizens. However, there is a growing trend among the middle and upper classes to seek out private healthcare services, including vaccinations. This trend has led to an increase in demand for Other Vaccines in the private healthcare sector.
Trends in the market: The Other Vaccines market in Costa Rica is expected to continue to grow in the coming years. There are several factors driving this growth, including an increase in disposable income, a growing awareness of the importance of vaccination, and an aging population. Additionally, the COVID-19 pandemic has highlighted the importance of vaccines, which may lead to an increase in demand for Other Vaccines in the future.
Local special circumstances: Costa Rica has a relatively high vaccination rate, with the majority of the population receiving vaccines through the public healthcare system. However, there are still gaps in coverage, particularly among the middle and upper classes. This has led to the development of a private healthcare sector that provides Other Vaccines to those who can afford it. Additionally, Costa Rica has a large expat population, many of whom prefer to receive healthcare services in English, which has led to the development of English-speaking private healthcare providers.
Underlying macroeconomic factors: Costa Rica has a relatively stable economy, with a growing middle class and a high level of human development. The country has a strong healthcare system, which has contributed to its high life expectancy and low infant mortality rate. Additionally, Costa Rica has a well-educated population, which has led to a growing awareness of the importance of vaccination. These underlying factors are expected to continue to contribute to the growth of the Other Vaccines market in the coming years.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
